BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8483812)

  • 1. Peptidases and smooth muscle cell angiotensin II receptor pharmacology.
    Cohen RB; Webb ML; Dickinson KE
    Peptides; 1993; 14(2):345-52. PubMed ID: 8483812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aorta.
    Fujimoto M; Mihara S; Shigeri Y; Itazaki K
    Eur J Pharmacol; 1992 May; 215(2-3):259-64. PubMed ID: 1396989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat.
    Harding JW; Yoshida MS; Dilts RP; Woods TM; Wright JW
    J Neurochem; 1986 Apr; 46(4):1292-7. PubMed ID: 3950629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells.
    Webb ML; Liu EC; Cohen RB; Hedberg A; Bogosian EA; Monshizadegan H; Molloy C; Serafino R; Moreland S; Murphy TJ
    Peptides; 1992; 13(3):499-508. PubMed ID: 1326103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH; Sullivan MJ; Wright JW; Harding JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of angiotensin-II receptor subtype on bovine thecal cells and its regulation by luteinizing hormone.
    Brunswig-Spickenheier B; Mukhopadhyay AK
    Endocrinology; 1992 Sep; 131(3):1445-52. PubMed ID: 1505474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are angiotensin receptors in vascular smooth muscles a homogeneous population?
    Tabrizchi R; Pang CC
    Eur J Pharmacol; 1987 Oct; 142(3):359-66. PubMed ID: 3428350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the adrenal angiotensin receptor angiotensin II--or angiotensin III like?
    Braley LM; Menachery AI; Underwood RH; Williams GH
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):116-21. PubMed ID: 6297210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human aortic smooth muscle cells containing angiotensin II type 1 receptors.
    Yazawa H; Iida-Kubota E; Honda K
    Jpn J Pharmacol; 1993 Aug; 62(4):339-43. PubMed ID: 8230860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of angiotensin receptors on bovine adrenal fasciculata cells.
    Vallotton MB; Capponi AM; Grillet C; Knupfer AL; Hepp R; Khosla MC; Bumpus FM
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):592-6. PubMed ID: 6264451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the binding and functional actions of angiotensin agonists in clone 9 cells: additional evidence for angiotensin II receptor heterogeneity.
    Kozlowski MR; Arcuri M; Zynardi L
    J Recept Res; 1993; 13(7):1031-40. PubMed ID: 8396180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.
    Briand V; Riva L; Galzin AM
    Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin I, II, and II tachyphylaxis in the mesenteric vascular circuit of the rat.
    Fasciolo JC; Binia A
    Hypertension; 1981; 3(6 Pt 2):II-166-70. PubMed ID: 7028614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding and internalization of a unique biologically active angiotensin II-colloidal gold conjugate: morphological analysis of angiotensin II processing in isolated vascular strips.
    Anderson KM; Peach MJ
    J Vasc Res; 1994; 31(1):10-7. PubMed ID: 7903871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of selective, high affinity [125I]-angiotensin and [125I]-bradykinin binding sites in rat intestinal epithelia.
    Cox HM; Munday KA; Poat JA
    Br J Pharmacol; 1986 Jan; 87(1):201-9. PubMed ID: 2869810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptors labelled with 125I-[Sar1, Ile8]-AII in albino rabbit ocular tissues.
    Mallorga P; Babilon RW; Sugrue MF
    Curr Eye Res; 1989 Aug; 8(8):841-9. PubMed ID: 2791629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells.
    Ullian ME; Linas SL
    J Clin Invest; 1989 Sep; 84(3):840-6. PubMed ID: 2760215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.